GSK3B, a serine-threonine kinase, has been associated with Alzheimer’s disease [49, 50] and may regulate human aging via negative regulation of glucose homeostasis and Wnt signaling. The gene discussed is MARK2; the disease is early-onset autosomal dominant Alzheimer disease.